Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Reply to Ploderl and Hengartner: learning about the course of suicidal behavior but not about the effects of SSRIs

This is a preview of subscription content, access via your institution

Access options

Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.


  1. Plöderl M, Hengartner MP. Learning about the course of suicidal behavior but not about the effects of SSRIs. Neuropsychopharmacology. 2021.

  2. Lagerberg T, Fazel S, Sjölander A, Hellner C, Lichtenstein P, Chang Z. Selective serotonin reuptake inhibitors and suicidal behaviour: a population-based cohort study. Neuropsychopharmacology. 2021.

  3. Björkenstam C, Möller J, Ringbäck G, Salmi P, Hallqvist J, Ljung R. An association between initiation of selective serotonin reuptake inhibitors and suicide-a nationwide register-based case-crossover study. PLoS ONE. 2013;8:e73973.

    Article  Google Scholar 

  4. Dragioti E, Solmi M, Favaro A, Fusar-Poli P, Dazzan P, Thompson T, et al. Association of Antidepressant Use With Adverse Health Outcomes: a Systematic Umbrella Review. JAMA Psychiatry. 2019;76:1241–55.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Zimmerman M, Balling C, Chelminski I, Dalrymple K. Have treatment studies of depression become even less generalizable? Applying the inclusion and exclusion criteria in placebo-controlled antidepressant efficacy trials published over 20 years to a clinical sample. Psychother Psychosom. 2019;88:165–70.

    Article  Google Scholar 

  6. Hernán MA, Robins JM. Using big data to emulate a target trial when a randomized trial is not available. Am J Epidemiol. 2016;183:758–64.

    Article  Google Scholar 

Download references


ZC is funded by the Swedish Research Council (2018-02213). SF is funded by the Wellcome Trust (#202836/Z/16/Z).

Author information

Authors and Affiliations



Conception: TL & ZC; Drafting: TL; Critical revisions: all authors.

Corresponding authors

Correspondence to Tyra Lagerberg or Zheng Chang.

Ethics declarations

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Lagerberg, T., Fazel, S., Lichtenstein, P. et al. Reply to Ploderl and Hengartner: learning about the course of suicidal behavior but not about the effects of SSRIs. Neuropsychopharmacol. 47, 804 (2022).

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI:


Quick links